Study of Leukocyte Populations in Patients With Chronic Inflammatory
NCT04749875 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2021-02-11
Summary
Exploration of pathophysiological mechanisms in chronic inflammatory rheumatism and rare systemic autoimmune diseases with the objective of identifying therapeutic targets.
Conditions
- Systemic Autoimmune Disease
- Chronic Inflammatory Rheumatism
- Sjogren's Syndrome
- Spondyloarthritis
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
Interventions
- OTHER
-
blood sample
sampling of blood for research during routine care
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Gaetane Nocturne · APHP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-03-01
- Primary Completion
- 2026-03-01
- Completion
- 2026-03-01
Countries
- France
Study Locations
More Related Trials
-
Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis
NCT03575156 ·Status: COMPLETED ·Phase: NA
-
Acquired Immunodeficiency in ANCA Associated Vasculitis
NCT03514979 ·Status: UNKNOWN ·Phase: PHASE2
-
Lymphocyte Sub-populations and Auto Immune Diseases
NCT03901664 ·Status: COMPLETED
-
Molecular Diagnosis of Systemic Autoinflammatory Diseases
NCT05364294 ·Status: RECRUITING
-
Anti-ficolin-3 Antibodies in Lupus Nephritis
NCT03842787 ·Status: COMPLETED
-
PRediction Of Flares In Lupus With autoantibodiEs and Chemokines
NCT04951427 ·Status: UNKNOWN
-
Differentiate Children Septic and Inflammatory Arthritis by Comparative Analysis
NCT03827759 ·Status: TERMINATED
-
Analysis of B Cells From Autoimmune Individuals
NCT02747277 ·Status: COMPLETED
-
Weaning of Immunosuppression in Nephritis of Lupus
NCT01284725 ·Status: COMPLETED ·Phase: PHASE3
-
Determining the Responses and Impact of Rituximab-instigated Cell Depletion on T Cells in People With SLE
NCT01702038 ·Status: WITHDRAWN ·Phase: PHASE2
-
Disease Activity Biomarkers in Patients With Systemic Lupus Erythematosus
NCT05443516 ·Status: RECRUITING
-
Transcriptional and Immune Parameters of Response to Belimumab
NCT04570306 ·Status: COMPLETED
-
Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus
NCT04877691 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study
NCT00271934 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of rhuMAb IFNalpha in Adults With Systemic Lupus Erythematosus
NCT00541749 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective Observational Study Evaluating the Safety and Efficacy of Immunomodulatory Therapies in Refractory Inflammatory and Autoimmune Diseases
NCT06757426 ·Status: NOT_YET_RECRUITING
-
Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)
NCT00657007 ·Status: COMPLETED ·Phase: PHASE1
-
Interferon-lambda: Novel Biologics for Controlling Neutrophil-mediated Pathology in Rheumatic Diseases?
NCT02498808 ·Status: UNKNOWN
-
Study of YK012 in Moderate to Severe Systemic Lupus Erythematosus
NCT07010835 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Autologous Stem Cell Transplantation: International Lupus Trial
NCT05063513 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or Biologics
NCT04870411 ·Status: TERMINATED
-
Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism
NCT05961267 ·Status: COMPLETED
-
Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People
NCT04844489 ·Status: COMPLETED ·Phase: NA
-
Natural History of Coronavirus Disease (COVID-19) in Systemic Autoimmune Diseases
NCT04690816 ·Status: COMPLETED
-
Covid-19 in Lupus Patients
NCT04355702 ·Status: COMPLETED